These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 16360341

  • 1. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
    Olivier A, Jeanson-Leh L, Bouma G, Compagno D, Blondeau J, Seye K, Charrier S, Burns S, Thrasher AJ, Danos O, Vainchenker W, Galy A.
    Mol Ther; 2006 Apr; 13(4):729-37. PubMed ID: 16360341
    [Abstract] [Full Text] [Related]

  • 2. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
    Charrier S, Stockholm D, Seye K, Opolon P, Taveau M, Gross DA, Bucher-Laurent S, Delenda C, Vainchenker W, Danos O, Galy A.
    Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro.
    Dewey RA, Avedillo Díez I, Ballmaier M, Filipovich A, Greil J, Güngör T, Happel C, Maschan A, Noyan F, Pannicke U, Schwarz K, Snapper S, Welte K, Klein C.
    Exp Hematol; 2006 Sep; 34(9):1161-9. PubMed ID: 16939809
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
    Frecha C, Toscano MG, Costa C, Saez-Lara MJ, Cosset FL, Verhoeyen E, Martin F.
    Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
    [Abstract] [Full Text] [Related]

  • 9. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.
    Candotti F, Facchetti F, Blanzuoli L, Stewart DM, Nelson DL, Blaese RM.
    Gene Ther; 1999 Jun; 6(6):1170-4. PubMed ID: 10455421
    [Abstract] [Full Text] [Related]

  • 10. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM, Tsuboi S, Wong A, Yu XJ, Oh-Eda M, Derry JM, Francke U, Fukuda M, Weinberg KI, Kohn DB.
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts.
    Mizutani K, Miki H, He H, Maruta H, Takenawa T.
    Cancer Res; 2002 Feb 01; 62(3):669-74. PubMed ID: 11830518
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection.
    Garmendia J, Carlier MF, Egile C, Didry D, Frankel G.
    Cell Microbiol; 2006 Sep 01; 8(9):1444-55. PubMed ID: 16922863
    [Abstract] [Full Text] [Related]

  • 18. Expression of WASP and Scar1/WAVE1 actin-associated proteins is differentially modulated during differentiation of HL-60 cells.
    Launay S, Brown G, Machesky LM.
    Cell Motil Cytoskeleton; 2003 Apr 01; 54(4):274-85. PubMed ID: 12601690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
    Avedillo Díez I, Zychlinski D, Coci EG, Galla M, Modlich U, Dewey RA, Schwarzer A, Maetzig T, Mpofu N, Jaeckel E, Boztug K, Baum C, Klein C, Schambach A.
    Mol Pharm; 2011 Oct 03; 8(5):1525-37. PubMed ID: 21851067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.